July 28, 2014

CSRWire.com The Corporate Social Responsibility Newswire
news by category

Can Corporate Sustainability & Economic Growth Coexist?


We chatted with SAP, BSR, CDP and 232 communicators.

Generating over 1,300 tweets.

9,437,880 impressions

&

Engaging over 377,000 Twitter accounts.

See more Analytics!

&

Let's chat!

Reversing Perception, Creating Impact:

We Chat with MGM's Executive Team!

MGM executive team

Generating 5.6 million impressions.

Engaging over 270,000 Twitter accounts.

With over 650 tweets.

mgm

See more Analytics!

&

Let's talk!

#BaBf: What Does it Mean to Brew a Better Future?

We chat LIVE with

Heineken

Generating 6.2 million impressions.

Engaging almost 300,000 Twitter accounts.

With  146 communicators.

And almost 800 tweets.

Heineken sustainability goals

See more Analytics!

&

Learn more about our Twitter Chats!

When Corporate Citizenship Integrates with Business Strategy: In Conversation with

HP Living ProgressGenerating 7.2 million impressions.

Engaging almost 1.3 million Twitter accounts.

With 193 communicators.

And almost 800 tweets.

See more Analytics!

&

Let's chat!


What Does it Mean
to Compete to be
Best FOR the
World?

We chatted LIVE
with:

Badger Balm, Indigenous Designs

Generating 8.1 million impressions.

With 128 communicators.

And almost 900 tweets.

See more Analytics!

&

Let's chat!

 Health & Wellness Press Releases

Open-uri20090515-26760-1tbt76v-0

Health and Wellness describes the general condition of body and mind and all living organisms, which is inextricably tied to environmental, physical, psychological, cultural, and social factors.

 CSR Press Releases

Submit Press Release

Press Releases are distributed to journalists at major media outlets, investment professionals, academics, analysts, activists and consumers, NGOs and nonprofits, sustainability and CSR organizations, corporate CSR officers and other professionals focused on Corporate Social Responsibility and sustainability.

Select from the menu to the right to filter by CSR Category

Wharton IGEL Partners with Johnson & Johnson to Help Healthcare Organizations Make the Case for Sustainability

Posted: Dec 05, 2013 – 02:38 PM EST

PHILADELPHIA, Dec. 05 /CSRwire/ - The Wharton School, through its Initiative for Global Environmental Leadership (IGEL), partnered with Johnson Johnson to convene healthcare professionals and share best practices for measuring the value of sustainability initiatives in the healthcare field. Those who attended the...

Le « Novartis Africa Day » met en Lumière les Initiatives de L’entreprise pour étendre L’accès aux Soins de Santé

Posted: Dec 05, 2013 – 01:15 AM EST

- Les difficultés de l’Afrique en matière de soins de santé sont aggravées par le développement des maladies non transmissibles, qui place le continent face à un double défi - Outre ses initiatives existantes en matière de responsabilité d’entreprise, notamment la « Malaria...

Novartis Africa Day Unterstreicht die Bemühungen des Unternehmens für Einen Besseren Zugang zur Gesundheitsversorgung

Posted: Dec 05, 2013 – 01:15 AM EST

- Die Herausforderungen für die Gesundheitsversorgung in Afrika werden dadurch erschwert, dass mit dem Anstieg nicht übertragbarer Krankheiten eine doppelte Krankheitsbelastung droht - Neben den bereits vorhandenen Massnahmen im Rahmen unserer gesellschaftlichen Verantwortung wie die Malaria Initiative setzt Novartis innovative kommerzielle Modelle um,...

Novartis Africa Day Highlights Company’s Efforts to Expand Access to Healthcare

Posted: Dec 05, 2013 – 01:15 AM EST

- Africa’s healthcare challenges are compounded as it begins to face a dual disease burden as non-communicable diseases rise - In addition to existing corporate responsibility efforts such as its Malaria Initiative, Novartis is implementing innovative commercial models, utilizing new technologies and increasing...

Novartis Foundation Launches New Leprosy Strategy at Symposium on Disease Elimination

Posted: Nov 29, 2013 – 01:20 AM EST

- The Novartis Foundation for Sustainable Development (NFSD) launches a new strategy to help eliminate leprosy. - For over 15 years, the annual symposium of the Novartis Foundation has provided an important platform for stakeholder dialogue on development and health policy issues.

Die Novartis Stiftung Lanciert Neue Leprastrategie an Ihrem Symposium über Krankheitseliminierung

Posted: Nov 29, 2013 – 01:19 AM EST

- Experten präsentieren Erfahrungen aus früheren Programmen zur Krankheitskontrolle und diskutieren neue Ansätze für die Ausrottung von Krankheiten wie Lepra und Malaria. - Die Novartis Stiftung für Nachhaltige Entwicklung (NFSD) lanciert eine neue Strategie, um die Eliminierung von Lepra zu unterstützen. - Seit...

La Fondation Novartis Lance Une Nouvelle Stratégie de Lutte Contre la Lèpre Lors de son Symposium Sur L’élimination des Maladies

Posted: Nov 29, 2013 – 01:18 AM EST

- Des experts exposent les enseignements tirés de programmes antérieurs de lutte et présentent de nouvelles approches visant à éliminer les maladies comme la lèpre ou le paludisme. - La Fondation Novartis pour un Développement Durable (NFSD) lance une nouvelle stratégie pour contribuer...

New Malaria Target Identified With Potential to Prevent, Block and Treat Multiple Stages of the Malaria Life Cycle

Posted: Nov 29, 2013 – 01:17 AM EST

BASEL, Switzerland, Nov. 29 /CSRwire/ - Novartis scientists have discovered a new drug target for treating malaria. The discovery, which is published online in the journal Nature,2 identifies phosphatidylinositol-4 kinase (PfPI4K) as the target of the imidazopyrazines, a novel experimental antimalarial compound class...

Neues Malaria-Target mit dem Potenzial zur Prophylaxe, Hemmung und Behandlung verschiedener Stadien des Malarialebenszyklus identifiziert

Posted: Nov 29, 2013 – 01:16 AM EST

BASEL, Switzerland, Nov. 29 /CSRwire/ - Wissenschaftler von Novartis haben ein neues Wirkstoff-Target zur Behandlung von Malaria gefunden. Ihrer Entdeckung zufolge, die in Nature online publiziert wurde,2 fungiert die Phosphatidylinositol-4-Kinase (PfPI4K) als Target fr Imidazopyrazine, eine neuartige, experimentelle Antimalaria-Wirkstoffklasse, welche die Entwicklung mehrerer...

Identification d'une nouvelle cible du paludisme ayant le potentiel de prévenir, bloquer et traiter plusieurs stades du cycle de vie du paludisme

Posted: Nov 29, 2013 – 01:15 AM EST

BASEL, Switzerland, Nov. 29 /CSRwire/ - Les chercheurs de Novartis ont dcouvert une nouvelle cible mdicamenteuse pour le traitement du paludisme. La dcouverte, publie en ligne dans la revue Nature,2 identifie phosphatidylinositol-4-kinase (PfPI4K) comme cible des imidazopyrazines, une nouvelle classe de molcules exprimentales...

 

Issuers of news releases and not csrwire are solely responsible for the accuracy of the content

Web Design & Development by Fuzz Productions & Singlebrook